老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Can-Fite Biopharma Ltd

3.08
-0.0900-2.84%
盘后：3.080.00000.00%19:08 EDT
成交量：1.37万
成交额：4.25万
市值：659.90万
市盈率：0.00
高：3.16
开：3.08
低：3.07
收：3.17
52周最高：25.40
52周最低：2.90
股本：214.25万
流通股本：210.50万
量比：0.38
换手率：0.65%
股息：- -
股息率：- -
每股收益(TTM):-1,791.0249
每股收益(LYR):-3,259.3317
净资产收益率：-178.24%
总资产收益率：-66.75%
市净率：1.18
市盈率(LYR):0.00

数据加载中...

总览公司新闻资讯公告
2020/02/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/11

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/10

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2020/02/07

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/07

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/07

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/04

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/04

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/03

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2020/02/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/31

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/24

招股说明书

Registration statement for certain foreign private issuers
2020/01/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多